a |
Parameter | Value |
CTV | 35 (25–43) |
D90 | 106 (106–108) |
D100 | 81 (77–85) |
V100 | 97 (96–98) |
V150 | 24 (22–32) |
V200 | 8 (7–10) |
D2 rectum | 57 (50–69) |
D2 urethra | 81 (76–85) |
DHI | 0.27 (0.22–0.33) |
b |
Region of interest | Mean (cGy) | Min (cGy) | Max (cGy) |
GTV | 4027 | 3462 | 4375 |
PTV | 3936 | 3134 | 4375 |
Bladder | 862 | 161 | 3680 |
Rectum | 727 | 102 | 3561 |
Right femoral head | 371 | 145 | 894 |
Left femoral head | 428 | 139 | 1075 |
- Note: CTV clinical target volume, D90 dose delivered to 90% of the CTV, D100 dose delivered to 100% of the CTV, V100 volume receiving 100% of the prescribed dose, V150 volume receiving 150% of the prescribed dose, V200 volume receiving 200% of the prescribed dose, D2 rectum dose delivered to 2% of the rectum volume, D2 urethra dose delivered to 2% of the urethra volume, DHI dose non-homogeneity Index: V150/V100
- Note: GTV gross target volume, PTV planning target volume